Your browser doesn't support javascript.
loading
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study.
Vaes, Rianne D W; Reynders, Kobe; Sprooten, Jenny; Nevola, Kathleen T; Rouschop, Kasper M A; Vooijs, Marc; Garg, Abhishek D; Lambrecht, Maarten; Hendriks, Lizza E L; Rucevic, Marijana; De Ruysscher, Dirk.
Afiliación
  • Vaes RDW; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
  • Reynders K; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
  • Sprooten J; Cell Stress & Immunity (CSI) Lab, Department for Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
  • Nevola KT; OLINK Proteomics Inc., Waltham, MA 02453, USA.
  • Rouschop KMA; Department of Radiotherapy, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
  • Vooijs M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
  • Garg AD; Cell Stress & Immunity (CSI) Lab, Department for Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
  • Lambrecht M; Department of Radiotherapy-Oncology, Leuven Kanker Instituut, Universitair Ziekenhuis (UZ) Gasthuisberg, 3000 Leuven, Belgium.
  • Hendriks LEL; Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
  • Rucevic M; OLINK Proteomics Inc., Waltham, MA 02453, USA.
  • De Ruysscher D; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
Cancers (Basel) ; 13(24)2021 Dec 13.
Article en En | MEDLINE | ID: mdl-34944879

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza